REPORTINGPHARM Trademark

Trademark Overview

On Wednesday, April 12, 2023, a trademark application was filed for REPORTINGPHARM with the United States Patent and Trademark Office. The USPTO has given the REPORTINGPHARM trademark a serial number of 97884473. The federal status of this trademark filing is REGISTERED as of Tuesday, April 8, 2025. This trademark is owned by Health Strategy, LLC. The REPORTINGPHARM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing temporary use of non-downloadable on-line, internet-based software platform enabling users to analyze a variety of information concerning pharmaceuticals
reportingpharm

General Information

Serial Number97884473
Word MarkREPORTINGPHARM
Filing DateWednesday, April 12, 2023
Status700 - REGISTERED
Status DateTuesday, April 8, 2025
Registration Number7756507
Registration DateTuesday, April 8, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkREPORTING HARM
Goods and ServicesProviding temporary use of non-downloadable on-line, internet-based software platform enabling users to analyze a variety of information concerning pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, May 6, 2023
Primary Code042
First Use Anywhere DateThursday, May 30, 2024
First Use In Commerce DateThursday, May 30, 2024

Trademark Owner History

Party NameHealth Strategy, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressPeoria, IL 61602
Party NameHealth Strategy, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPeoria, IL 61602

Trademark Events

Event DateEvent Description
Saturday, April 15, 2023NEW APPLICATION ENTERED
Saturday, May 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 9, 2024ASSIGNED TO EXAMINER
Tuesday, January 16, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 16, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 1, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, May 1, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, June 27, 2024NOTICE OF REVIVAL - E-MAILED
Thursday, June 27, 2024PETITION TO REVIVE-GRANTED
Thursday, June 27, 2024TEAS PETITION TO REVIVE RECEIVED
Thursday, June 27, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 11, 2024ASSIGNED TO LIE
Tuesday, October 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 28, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, October 28, 2024FINAL REFUSAL WRITTEN
Friday, December 27, 2024TEAS AMENDMENT OF USE RECEIVED
Friday, December 27, 2024USE AMENDMENT FILED
Friday, December 27, 2024AMENDMENT TO USE PROCESSING COMPLETE
Thursday, March 13, 2025USE AMENDMENT ACCEPTED
Thursday, March 13, 2025APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Thursday, March 13, 2025LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 8, 2025REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, April 8, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, December 27, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, October 28, 2024FINAL REFUSAL E-MAILED

Related Keywords

reportingpharm analyze users variety information pharmaceuticals concerning enabling platform downloadable temporary